Cory J Arrouzet1, Karen Ellis1, Anita Kambhampati2,3, Yingxi Chen4, Molly Steele5, Ben Lopman1,2,5. 1. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA. 2. Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 3. IHRC, Inc., Atlanta, Georgia, USA. 4. Research School of Population Health, Australian National University, Canberra, Australia. 5. Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Abstract
BACKGROUND: Noroviruses are a leading cause of acute gastroenteritis. Genogroup 2 type 4 (GII.4) has been the dominant norovirus genotype worldwide since its emergence in the mid-1990s. Individuals with a functional fucosyltransferase-2 gene, known as secretors, have increased susceptibility to GII.4 noroviruses. We hypothesized that this individual-level trait may drive GII.4 norovirus predominance at the human population level. METHODS: We conducted a systematic review for studies reporting norovirus outbreak or sporadic case genotypes and merged this with data on proportions of human secretor status in various countries from a separate systematic review. We used inverse variance-weighted linear regression to estimate magnitude of the population secretor-GII.4 proportion association. RESULTS: Two hundred nineteen genotype and 112 secretor studies with data from 38 countries were included in the analysis. Study-level GII.4 proportion among all noroviruses ranged from 0% to 100%. Country secretor proportion ranged from 43.8% to 93.9%. We observed a 0.69% (95% confidence interval, 0.19-1.18) increase in GII.4 proportion for each percentage increase in human secretor proportion, controlling for Human Development Index. CONCLUSIONS: Norovirus evolution and diversity may be driven by local population human host genetics. Our results may have vaccine development implications including whether specific antigenic formulations would be required for different populations.
BACKGROUND: Noroviruses are a leading cause of acute gastroenteritis. Genogroup 2 type 4 (GII.4) has been the dominant norovirus genotype worldwide since its emergence in the mid-1990s. Individuals with a functional fucosyltransferase-2 gene, known as secretors, have increased susceptibility to GII.4 noroviruses. We hypothesized that this individual-level trait may drive GII.4 norovirus predominance at the human population level. METHODS: We conducted a systematic review for studies reporting norovirus outbreak or sporadic case genotypes and merged this with data on proportions of human secretor status in various countries from a separate systematic review. We used inverse variance-weighted linear regression to estimate magnitude of the population secretor-GII.4 proportion association. RESULTS: Two hundred nineteen genotype and 112 secretor studies with data from 38 countries were included in the analysis. Study-level GII.4 proportion among all noroviruses ranged from 0% to 100%. Country secretor proportion ranged from 43.8% to 93.9%. We observed a 0.69% (95% confidence interval, 0.19-1.18) increase in GII.4 proportion for each percentage increase in human secretor proportion, controlling for Human Development Index. CONCLUSIONS: Norovirus evolution and diversity may be driven by local population human host genetics. Our results may have vaccine development implications including whether specific antigenic formulations would be required for different populations.
Authors: Janko van Beek; Miranda de Graaf; Haider Al-Hello; David J Allen; Katia Ambert-Balay; Nadine Botteldoorn; Mia Brytting; Javier Buesa; Maria Cabrerizo; Martin Chan; Fiona Cloak; Ilaria Di Bartolo; Susana Guix; Joanne Hewitt; Nobuhiro Iritani; Miao Jin; Reimar Johne; Ingeborg Lederer; Janet Mans; Vito Martella; Leena Maunula; Georgina McAllister; Sandra Niendorf; Hubert G Niesters; Alexander T Podkolzin; Mateja Poljsak-Prijatelj; Lasse Dam Rasmussen; Gábor Reuter; Gráinne Tuite; Annelies Kroneman; Harry Vennema; Marion P G Koopmans Journal: Lancet Infect Dis Date: 2018-01-26 Impact factor: 25.071
Authors: Geert Leroux-Roels; Jakob P Cramer; Paul M Mendelman; James Sherwood; Ralf Clemens; Annelies Aerssens; Ilse De Coster; Astrid Borkowski; Frank Baehner; Pierre Van Damme Journal: J Infect Dis Date: 2018-01-30 Impact factor: 5.226
Authors: Anita Vinjamuri; Jasmine C C Davis; Sarah M Totten; Lauren D Wu; Laura D Klein; Melanie Martin; E A Quinn; Brooke Scelza; Alicia Breakey; Michael Gurven; Grazyna Jasienska; Hillard Kaplan; Claudia Valeggia; Katie Hinde; Jennifer T Smilowitz; Robin M Bernstein; Angela M Zivkovic; Michael J Barratt; Jeffrey I Gordon; Mark A Underwood; David A Mills; J Bruce German; Carlito B Lebrilla Journal: J Nutr Date: 2022-05-05 Impact factor: 4.798